Viking Therapeutics, Inc. (VKTX)
NASDAQ: VKTX · Real-Time Price · USD
29.99
+0.04 (0.13%)
Sep 16, 2026, 10:33 AM EDT - Market open
Viking Therapeutics Employees
Viking Therapeutics had 65 employees as of June 30, 2026. The number of employees increased by 16 or 32.65% compared to the same quarter last year.
Employees
65
Change
16
Growth
32.65%
Revenue / Employee
n/a
Profits / Employee
-$8,227,631
Market Cap
3.50B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Legend Biotech | 2,965 |
| Telix Pharmaceuticals | 1,184 |
| Iovance Biotherapeutics | 975 |
| AbCellera Biologics | 562 |
| Denali Therapeutics | 507 |
| Tarsus Pharmaceuticals | 370 |
| Dyne Therapeutics | 289 |
| Celcuity | 155 |
VKTX News
- 1 day ago - Viking Therapeutics Transcript: Morgan Stanley 24th Annual Global Healthcare Conference - Transcripts
- 13 days ago - Viking Therapeutics to Participate at Upcoming Investor Conferences - PRNewsWire
- 22 days ago - Der Aktionaer editor speculates on timing of Viking Therapeutics data - TheFly
- 5 weeks ago - Viking Therapeutics price target lowered to $65 from $75 at JPMorgan - TheFly
- 5 weeks ago - Viking Therapeutics participates in a conference call with Cantor - TheFly
- 6 weeks ago - Viking Therapeutics Slides: Corporate presentation - Filings
- 6 weeks ago - Viking Therapeutics price target raised to $114 from $107 at Canaccord - TheFly
- 6 weeks ago - Viking Therapeutics files automatic mixed securities shelf - TheFly